This prospective observational study was done in National Institute of Cardiovascular Diseases and hospital Dhaka, during the period April 2002 toJuly 2008. In this study the immediate results of balloon mitral valvuloplasty with mitral restenosis patients with previous surgical mitral commissurotomy was evaluated. We have done 50 cases of percutaneous balloon mitral valvuloplasty in patients who had the history of previous surgical commissurotomy. Out of these 50 patients 8 patients were male and 42 patients were female. The age range was 25-55 years with duration of surgical commissurotomy (SC) of 2-18 years past. The result of balloon mitral valvuloplasty (BMV) was successful in 48 cases and failed in 2 cases due to huge left atrium, balloon did not negotiate from LA to LV. Mitral valve area (MVA) before the procedure was 0.5-0.9 sq cm with mean 0.7± 2 sq cm. Following procedure the MVA was 1.6-2.04 cm 2 with a mean of 1.8±0.2 cm2. Gradient across mitral valve (MV) before and after the procedure was 20-44 mm Hg with a mean of 32±-12 mm Hg and 8-12 mmHg with a mean of 10±2 mm Hg. MVA >1.8 cm 2 was achieved in 41 cases &1.8-1.6 cm 2 in 7 cases. Mitral regurgitation >1 grade occurred in 8 cases. So we conclude that BMV in patients with mitral restenosis following SC can be performed successfully with low risk of major cardiac complications.
Introduction
The prevalence of mitral stenosis in developed countries, is 0.5 /100,000. Its prevalence in developing countries is at least 10 times higher than in developed countries. 1 Closed mitral commissurotomy is still considered as a treatment of choice in developing countries in particular for economic reason. It is estimated that about 10-30% of patients developed restenosis 5-10 years after an initial successful surgical commissurotomy. 2 The efficacy of Percutaneous balloon mitral valvuloplasty (BMV) in patients with unoperated mitral stenosis has been well documented though there exists less clear-cut data on its effectiveness in patients with mitral restenosis following closed mitral commissurotomy (CMC). Therefore, in this study, we analyzed our results obtained with balloon mitral valvuloplasty in patients with mitral restenosis after previous surgical commissurotomy.
Methods
This study was done in National Institute of Cardiovascular Diseases (NICVD), Dhaka, Bangladesh. We performed 50 cases of BMV in patients who had the history of previous surgical commissurotomy. Among 50 patients undergoing BMV who received the procedure for symptomatic mitral restenosis after the duration of 2-18 years past the CMC.
There were 42 female and 8 male with age range 25 to 55 years. Echocardiographic score of the mitral apparatus, baseline mitral valve area were determined by echocardiography Presence of mitral regurgitation as determined by Color Doppler echo. 
Balloon mitral valvuloplasty technique
Balloon mitral valvuloplasty was performed using an appropriate sized Inoue balloon catheter determined from the height of the patients and the stepwise dilatation technique. [3] [4] The reference balloon size (RBS) in mm was determined from the height of the patient using the formula RBS = H/10+10 in mm where H is the patients height in cm e.g. if the height is 160 cm then the RBS will be 160/10+10 = 16+10 = 26 mm. [3] [4] Balloon mitral valvuloplasty was terminated once a satisfactory hemodynamic result defined as a decrease of at least one half the initial transmitral gradients with no further reduction despite two or three more dilatations using larger balloon sizes of 0.5-1.0 mm increments was obtained ( Fig:1 & 2) .
Echocardiography
All patients underwent 2D-E, M mode and Colour Doppler echocardiographic examination before and 2-4 weeks after balloon mitral valvuloplasty. Transesophageal echocardiography was performed 1-2 days prior to balloon mitral valvuloplasty to those patients having the history of previous left atrial thrombus or haziness found in left atrial appendage by transthoracic echocardiography. In this study mitral valve area (cm 2 ) were determined by planimetry and Doppler Pressure half time (PHT). Mitral valve area and subvalvular morphology was graded according to the Wilkins scoring system which assigns higher scores to values with more severe disease. 5   Table II : Depicts hemodynamic changes and mitral valve area before and after the procedure (n=50) The composite end point of good immediate results used in this study associates a mitral valve area 1.5 cm2 and no regurgitation >2/4, such conditions generally providing normal hemodynamic. [13] [14] Patients who have a history of prior commissurotomy have more severe impairment of valve anatomy. Our findings are consistent with the work of Feldman et al. 15 who showed that the impairment of valve anatomy was not a predictor of poor results of BMV. Valve calcification and the duration between surgery and BMV have been identified as predictors in other series [6] [7] [8] , but not in ours. It should be noted that valve calcification, when present, was generally mild or moderate in the patients of this series. There was no procedural related mortality and no cardiac perforation, stroke or emergency mitral valve surgery in the study.
Only limited data exist on the short and midterm results of balloon mitral valvuloplasty in patients with mitral restenosis after previous surgical commissurotomy. [16] [17] [18] [19] The results of balloon mitral valvuloplasty in such a setting have been mixed. Davidson et. al. 16 noted that balloon mitral valvuloplasty in these patients was associated with a significant smaller gain in mitral valve area and less sustained clinical benefits compared with those without prior mitral surgery. In contrast, our findings concurred with several other past studies [6] [7] [8] in that balloon mitral valvuloplasty yielded similar immediate improvement in the valve area and an identical risk of resultant mitral regurgitation. More recent data in a study from Boston 10 revealed that although the immediate and midterm results in patients with mitral restenosis after previous surgical commissurotomy were generally inferior to those without past mitral surgery, these differences were no longer observed when patients with favorable overall mitral echo score (<8) were compared. However, the present study differs from some of these studies [17] [18] [19] with respect to the incidence of technical failures, resultant severe mitral regurgitation and morbidity. Serra et.al. 19 observed technical failure and major cardiac related complications in 11% of patients in their study. Medina et. al. 17 in turn, noted resultant severe mitral regurgitation in 9.5% of patients and cited a 4.7% mortality rate. In contrast, there was no technical failure, severe mitral regurgitation or death in our patients with previous surgical commissurotomy. Possible explanations for these major discrepancies include the use of the Inoue balloon in the present study as opposed to the double balloon technique used in all the above mentioned studies and patient selection. This study demonstrates that balloon mitral valvuloplasty is safe in patients with mitral restenosis following prior surgical commissurotomy.
In conclusion it can be said that balloon mitral valvuloplasty in patients with mitral restenosis following surgical commissurotomy can be performed successfully with low risk of major cardiac complications. For these reasons balloon mitral valvuloplasty should be considered a logical first line of following surgical commissurotomy treatment strategy for selected patients of mitral restenosis.
